




This chapter examines the social, economic and political contexts of gendered 
inequality, vulnerability and agency in which the war on drugs takes place. As the 
previous chapter has demonstrated, the drug war is failing and causes multiple 
harms. Those harms are not evenly distributed: they affect overwhelmingly those 
in society who are most susceptible to being cast as socially undesirable or as 
violating moral and social norms. Ethnicity, gender, age, social class and occupa-
tion are some of the key factors that combine to produce ‘punishable subjects’ in 
drug policy. This chapter unpicks some of the ways in which women’s continuing 
inequality in all spheres plays out in drug policy. How do women continue to be 
framed, included or excluded in key fields of policy and practice such as develop-
ment, healthcare and security?
Gender: Framing Women
Gender is perhaps the most fundamental of organising principles in human soci-
ety and it operates in a number of different ways. First, gender is both a personal, 
assumed identity and a socially ascribed identity, and these may line up, or be in 
conflict. For most (cis-gender) people, the gender they are assigned at birth, gen-
erally on the basis of observable physical characteristics, remains congruent with 
the gender that they feel themselves to be. However, for transgender individuals, 
the gender they are assigned at birth conflicts with the one that they identify 
with. Continuing research has revealed both biological sex and the factors that 
produce gender identities to be far more complex than simple binaries suggest. 
However, drug policy, in its different forms and contexts, often relies on Mani-
chean oppositions and seeks to discipline those whose behaviours or identities do 
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not conform. This tendency has been exacerbated in the current period of far-right 
populist nationalism, discussed below.
Gender is also a performance, a collection of practices, symbols and actions 
that signal to others how we wish to be seen, what kind of man or woman we 
are or what kind of gender identity we wish to project. For example, intoxica-
tion, particularly through alcohol use, is strongly associated with masculinity in 
many cultures, and something that men often feel obliged to perform in order to 
gain acceptance from other men. Conversely, as Ingrid Walker points out in this 
volume, women are expected to perform sobriety, whether in relation to drugs or 
alcohol, and female intoxication often elicits social opprobrium.
Almost universally, each social group has developed identifiable sets of gen-
dered expectations about how women and men should perform gender, what 
social roles they should take on and what the consequences should be if  they 
contravene those social norms. Whilst gender expectations vary in their detail 
from society to society, and change over time, some tropes seem to be very per-
vasive and explain why women seem to be either missing from drug policy or 
framed by particular sets of ideas and ideologies. One of the strongest tropes is 
the association of women with motherhood, with care and with nurturing. Every 
social norm requires its anti-norm, so praise for the ‘good mother’ means that 
other mothers must be punished for being ‘bad’ or ‘failing’ mothers. The flipside 
of the mother-and-wife is the sex-worker, the promiscuous or degenerate woman. 
Notions of purity and passivity are upset when women get involved with drugs as 
consumers seeking pleasure.
Gender is also a discourse that attaches to all kinds of phenomena, including 
abstract ideas. For example, ‘risk-taking’ is strongly associated with masculinity 
(Byrnes, Miller, & Schafer, 1999) yet, like any abstract idea, it needs breaking 
down into subcomponents (e.g., what kinds of risk, in what contexts) before then 
being tested empirically and with gender-disaggregated data (Harris, Jenkins, & 
Glaser, 2006). The fields that this chapter will concentrate on – development, 
health, security – are underpinned by key ideas whose meaning is assumed and 
very often tied to empirical data or suppositions that do not take account of 
women’s lived experience. The discounting of women affects, for example, how 
women are treated by medical professionals when they report pain. They are less 
likely to be given effective painkillers, and more likely to be offered antianxiety 
medication, by doctors who simply do not believe women’s self-reported symp-
toms. The relationship between pain, trauma histories and the failure of public 
agencies to respond to women’s needs is part of the gendered story of drug use.
Gender Analysis
Analysing any social phenomenon from a gender perspective involves asking a 
series of questions. In what way do social processes and experiences affect men, 
women and sexual and gender minorities in distinct ways? How do those dif-
ferent experiences produce relative power disparities, discrimination or dispro-
portionality? How are those disparities also affected by intersectional differences 
between different women, men and sexual and gender minorities? How does 
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policy address these disparities, seek to diminish them or end up reinforcing 
them? A comprehensive analysis would differentiate the many different stages 
of a process and generate gender-related questions for each of those decision-
making points. It would also involve a gender audit of the institutions involved 
in policy and practice, examining their gendered composition, structures and 
organisational culture. For example, when looking at the criminal justice sys-
tem’s response to illegal narcotics, a gender-sensitive approach would look at who 
makes law (representativeness), what evidence they draw on, whose voices are 
heard in consultation, the gender composition of the criminal justice agencies, the 
gender selectivity of searches and arrests for drugs, gender bias in pre-trial deten-
tion and sentencing and gender-disaggregated data on the various dispositions 
applied to those who produce, supply or consume drugs. Once we can see the 
extent to which women and men are treated differently by gathering quantitative 
data, we can answer the even more interesting questions about why this occurs, 
which requires data of a more qualitative nature. Unfortunately, a lot of research 
on drugs is still gender-blind.
An important distinction when trying to improve our understanding of 
women’s experiences of  drugs and drug policy, versus that of  men is that 
between equality and equity. The classic liberal idea of  equality is that of  equal 
treatment where equal is understood to mean ‘identical’. However, we do not 
have identical lives. We all live within complex sets of  identities, experiences 
and social expectations of  which gender is one component. Therefore, any ‘one 
size fits all’ policy that appears to offer exactly the same services to all users 
will inevitably be appropriate only for the subgroup whose social reality that 
service most closely approximates. For example, studies of  needle-exchange 
programmes showed that women were less willing to use pharmacy-based ones 
because they were more sensitive than men to the risk of  being seen in public 
and experiencing the more acute social shame of  being recognised as a drug 
user. The term gender ‘equity’, however, takes account of  the distinct life trajec-
tories of  men and women (and of  subgroups within these) and develops policies 
and practices that are differentiated but end up in equivalent outcomes. In the 
area of  medicine, for example, the dosage of  a drug to produce the same overall 
effect should take into account age, weight, sex and other variables. The fact 
that so many clinical trials on drugs have been conducted only on men means 
that whilst the treatment offered may be ‘equal’, it is not ‘equitable’ as it has not 
been adjusted for different beneficiaries in order to still achieve the common 
outcome intended.
Gender analysis, therefore, needs to be multi-layered and take account of com-
plexity. However, gender policy is often reductionist, simplistic and the result of 
a search for simple propositions, and policies that can be copied, multiplied and 
transferred. The most simplistic approach, long criticised in the field of women 
and development, is the ‘add women and stir’ one, where it is assumed that it is 
sufficient to have women in the room, as researchers, policymakers or research 
subjects. Whilst this is undeniably necessary, it is not sufficient, because gender 
sensitivity in any policy field only comes about through training, research and 
auditing practices and deeply held assumptions.
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Why Gendering the Field of Drugs Is So Hard
There are a number of reasons why insufficient attention has been paid to how 
drug policy affects women. First, the issue straddles a number of policy fields, 
and these fields themselves have long existed as siloed policy communities, where 
there is little interaction or exchange of ideas. This is often entrenched by the 
existence of separate United Nations (UN) bureaucracies, conferences and hard 
or soft law governing each field. The gendered impacts of drug policy fall within 
the fields of development, human rights, women’s rights, public health, crimi-
nal justice and national/international security, yet it has taken years for certain 
areas to begin a dialogue. For example, women’s rights were long understood in 
the international system as being synonymous with a certain narrow interpreta-
tion of ‘development’ that involved empowering women economically and giving 
them equal legal rights within the modernising framework of the policy approach 
that came to be known as ‘women in development’. Women’s agency over their 
own bodies was present to some extent in this development field under the head-
ing of population control, and the observation that family planning was both the 
result and the driver of women’s empowerment and better human welfare within 
the family. But complete bodily autonomy for women has been controversial 
since the landmark International Conference on Population and Development 
held in 1994. The Cairo Programme of Action emphasised sexual and reproduc-
tive health as a fundamental human right, a notion still strongly contested by 
regimes founded on religious fundamentalism and conservatism. In many coun-
tries, women remain semi-subjects, only partially in control of their own bodies.
The human rights and the women’s rights fields had not crossed over until the 
1993 UN conference on human rights in Vienna, where women’s equal possession 
of rights was strongly asserted and finally accepted. Drug policy internationally 
has been more developed as a criminal justice or national/international security 
concern, than a public health issue. The former two fields have been much more 
resistant than the development of human rights to incorporating a gender analy-
sis. The actors in these fields have been overwhelmingly male until very recently. 
Even with the entry of women into the police and the armed forces, the leadership 
and internal culture of these organisations remain male-dominated. The mean-
ing of ‘security’ lies in the hands of those who define it, that is, the politicians, 
the legislators, the police chiefs and the street-level police officers. Any social fact 
can be ‘securitised’, that is, framed as a security threat on which to build a moral 
panic that will justify the mobilisation of security resources to deal with it. Whilst 
women’s involvement in drug production or consumption is rarely seen as the 
kind of security threat that leads to direct violence, it is often construed as a more 
existential security threat to the moral fabric of society. This partly explains why 
the number of women ending up in prison for drugs offences has been increasing 
at a rate up to four times that of men, even though the vast majority of offences 
are non-violent.
There is also the issue of how each of these fields understands and frames 
gender issues. We all use schemas, that is, shortcuts to simplifying complexity. We 
want to be able to boil things down to a single proposition or policy proposal that 
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everyone can understand. For example, in development policy circles, it is easy to 
default to simplistic schemas such as ‘let’s help women because many are moth-
ers or heads of household’. Such a schema sees women as having a primary or 
singular social role. This ignores all the other possible roles and identities that she 
might have concurrently, or at some other stage in her life. It also excludes women 
who are not mothers due to choice or circumstance such as age. Furthermore, this 
schema relies on the idea that women are to be targeted not to assist them per se, 
but as the means to some other end. A great deal of development policy seeks to 
empower women through literacy, better healthcare or income generation so that 
they can better provide for and care for others. For instance, women’s literacy is 
closely linked to improvements in infant mortality, yet that should not be the only 
reason to increase women’s capabilities. Making policy for women that is instru-
mental – using them to achieve some other end – is problematic not just because 
it excludes many women but also because it treats those in the target group in an 
essentialist and reductionist way. However, this tactic of focussing on a social role 
that is unobjectionable across the political spectrum is often used as a ‘wedge’ in 
trying to begin a conversation about women where there is apparent hostility to 
seeing women as holders of certain kinds of rights and agency.
For example, the ‘women-as-mothers’ discourse has been used frequently by 
reformers on criminal justice reform as an argument for not sending women to 
prison for non-violent offences due to their care responsibilities as mothers. But 
can strategic maternalism be a lever into women’s issues, and can women’s issues 
be a lever into gender analysis? This approach would start by attending to what 
Maxine Molyneux calls practical gender interests. In a society where the primary 
caring duties are allocated to them, then public policy that makes it easier for 
women to perform a role that is important to them, their identity, and often their 
social status, is empowering to those women in the short term. Whether meeting 
these practical gender needs then reinforces a conservative narrative that carers 
should be women and women should be carers depends on the way that campaign 
organisations proceed beyond these pragmatic policies, and frame and reframe 
the issues. Changes over the longer term in gender relations require deeper atten-
tion to strategic gender interests, that is, applying a gender analysis that questions 
why women and men are allocated distinct social roles. In the instance of decar-
cerating female offenders, a more gender-strategic policy would be to evaluate the 
family care responsibilities of any person incarcerated for any non-violent drug 
offence, and to sentence on the basis of that criterion, rather than the sex of the 
offender. The question for policy is, do we want to assist marginalised groups such 
as women in the short term, according to their current needs, or do we also want 
to promote longer term change that recognises a much wider diversity of experi-
ences and needs that are not tethered to a single, homogeneous gender identity?
This is a genuine dilemma in policy-making and social activism. Women are 
the minority in so many contexts, treated as an after-thought, as the exception 
to the male norm, that it is quite reasonable from an equality and equity 
perspective to advocate policies that attend to women as a social group in order 
to raise their profile as subjects of a policy field in order to improve their vis-
ibility and encourage more appropriate policy. However, ‘women’ is just a social 
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category that contains within it an infinite variety of experience as gender 
intersects with race, class, (dis)ability and many other variables.
One of the other dominant frames for women is ‘vulnerability’. Women are 
seen, collectively, as a social group that is lacking in agency and needing pro-
tection, encapsulated in the term ‘women and children’. As Enloe (2017) points 
out, this phrase infantilises women by association, whereas the terminology that 
feminists made the UNHCR adopt, ‘women and their dependent children’, high-
lights women’s adult agency as providers. Patriarchal cultures do render women 
vulnerable in many instances to being victimised and used by third parties, for 
instance, in producing, taking or selling drugs, but this understanding needs to be 
carefully balanced against recognition of their agency. Feminist research suggests 
that both conditions may coexist in the same person, in the same context and it 
takes little to shift the balance. In studying a social phenomenon such as women’s 
involvement as mules in drug trafficking, ethnographic research reveals that some 
women feel victimised, others feel empowered and others feel a mixture of both 
(Fleetwood, 2014). The same is true of women’s involvement in drug trafficking 
gangs. They gain some social status and autonomy from the family but also run 
very specific risks of certain kinds of gendered violence, of which they are often 
aware and are attempting to manage (Moloney, Hunt, & Joe-Laidler, 2015). This 
vulnerability and dependency framework is a hangover from mainstream and 
development economics, where women’s contribution to family production and 
income generation is so often seen as incidental and peripheral, largely because 
it is indirect and thus invisible and unquantifiable. Yet, women’s time and labour 
are often central to these enterprises, and frequently bring specific resources and 
skills, such as social and familial capital (Denton & O’Malley, 1999).
Women as Exceptional and ‘Abnormal’
Seeing men as a group as having more agency, personhood and social importance 
than women has led to a structural bias across a multitude of research and policy 
areas. Caroline Criado-Perez’s (2019) book Invisible Women lays out in detail 
both gender gaps in data and data bias in science, design, medicine and many 
other fields. As she notes, data determine how resources are allocated and bad 
data result in bad resource allocation. Whole fields of research have been built 
on investigating only men’s experience as the norm against which women figure 
as the exception. Women have either been excluded from activities or forced to 
adapt to the absence of equipment anatomically designed for women, from rac-
ing bicycle saddles to astronauts’ suits and bullet-proof vests for police officers. 
The foundational studies in psychology in the post-war period were conducted 
on US university campuses using samples of convenience – the young white male 
college students sitting in the researchers’ classes. Preclinical research and clini-
cal trials of drugs have often been done only on men because women’s hormo-
nal cycle was regarded as ‘too complicated’. Women are, biologically, different 
from men in many complex ways due to a myriad of biological attributes at every 
level of the organism: macro, micro, cellular and molecular, and women’s indi-
vidual biology also varies, woman to woman, given the complex interactions of 
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chromosomes, genes and hormones. All these variables play a part in how drugs 
affect individuals.
When women are regarded as minority consumers of a good, their needs are 
rarely designed in. One example is women’s prisons. Globally, a few decades ago 
women represented only 3% of the prison population. The war on drugs has 
pushed this up to around 6%, but this still represents a tiny fraction of the prison 
population. As a result, women are generally incarcerated very far from home, as 
there are so few female prisons. Often, they are housed in poor quality facilities: 
in Brazil, men’s prisons and juvenile detention centres that were regarded as no 
longer fit for purpose have been repurposed as female prisons. In the UK, there 
are only 12 women’s prisons in England, none in Wales, one in Scotland, with 
some women also detained in units inside men’s prisons, and in Northern Ireland 
women are held in a unit within a male Young Offenders Institution.1 Or, even if  
the prison is built specifically for women, it will resemble a male prison ‘minus the 
urinals and painted pink’ (Maiello & Carter, 2015). This gender-insensitive cus-
todial environment rarely takes account of women’s specific social relations and 
background. Far more women than men in the prison system have trauma histo-
ries of neglect, sexual abuse and domestic violence, which often lead to the sub-
stance abuse, chronic health conditions and relationship difficulties that may be 
implicated on them receiving a prison sentence. A very high proportion of women 
are now in prison for offences related to drugs, often involving third parties. In 
the UK, 48% of women in custody committed an offence to support the drug use 
of someone else, whilst 39% had problematic drug use at the point of entering 
prison. Once inside prison, women’s experiences differ from men’s, with higher 
rates of mental illness and self-harm. Aside from the observation that prison is, 
therefore, the most inappropriate environment for women with such complex 
needs, rarely are prisons designed to take into account women’s actual needs, such 
as mental health, menstruation, relationship partners, sexuality, pregnancy and 
childbirth. Despite the development of the Bangkok Rules on women’s incarcera-
tion (UN General Assembly, 2010), women’s specific needs are still rarely met in 
custodial environments.
Who Makes Policy?
The aspiration set out in the political statements of the 1998 and 2016 United 
Nations General Assembly Special Session on Drugs (UNGASS) that member 
states should ‘ensure that women and men benefit equally, and without discrimina-
tion, from strategies directed against the world drug problem’ is laudable, but inevi-
tably runs up against the reality that nowhere in the world is there complete gender 
equality in all relevant spheres of policy-making and decision-making. Some of 
the countries with the most entrenched problems around drug production and 
consumption, such as Afghanistan, have the deepest forms of patriarchy, in which 
women’s agency is negligible and fiercely resisted by many actors (Enloe, 2017). 
1https://www.womeninprison.org.uk/research/key-facts.php
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The 1998 action plan also urges that alternative development programmes should 
‘incorporate a gender dimension by ensuring equal conditions for women and men 
to participate in the development process, including design and implementation’. 
Participation requires political will as well as attention to all the ways in which 
women are excluded from consultation, unless the methods employed are gender-
aware and provide equal conditions of access.
Women still have relatively less agency than men when it comes to making laws 
and determining public policy because in the overwhelming majority of coun-
tries in the world they are in a minority in elected legislative office. However, 
having voice on key social policies is not just a matter of numbers. It also mat-
ters where policy is forged. If  drugs are framed as a public health issue, then the 
medical establishment, Ministry of Health and any relevant health-related com-
mittees in the legislature are likely to have most significant input. Although the 
medical field has many gender biases in its data collection and research protocols, 
its professional hierarchies and its treatment of patients (medicalising women in 
very specific ways), health is associated with care and thus is regarded as a rela-
tively ‘feminised’ field.2 Whilst women constitute only 30% of health ministers 
worldwide, women politicians are more likely to get this portfolio, or some other 
regarded as connected to social welfare.3
When drug policy becomes highly securitised, then it shifts into what has his-
torically been a domain monopolised by men. Women are much less likely to hold 
leadership posts linked to security. In 2018, there were just 17 women defence 
ministers around the world. The Ministry of the Interior or of Justice is also a 
key position, as this is the government office that generally governs policing and 
law and order and is often central to criminal justice reform. Senior police officers 
and jurists who draw up the laws will be men, whilst the street-level bureaucrats – 
the police officers and local judges who sentence – are also still likely to be men 
and to reflect dominant social views about good women and fallen women.
The development field has been more gender sensitive, at least since the 1970s 
as the women-in-development movement gained ground, insisting that women’s 
specific experiences and contributions needed to be recognised and reflected in 
policy. Yet, when security meets development, security – a musculinised field still 
barely touched by gender sensitivity – tends to dominate. Like all policy fields it 
wants quick fixes and so solutions such as crop substitution are rolled out with-
out careful examination of local dynamics and gender relations. Where women 
are heads of household and carers, having to meet their practical gender needs, 
then alternative development approaches that ignore this imperative and make 
male-centric assumptions about literacy, access to credit and land ownership 
patterns and rights will simply not work.
2Women currently constitute 70% of the global health workforce but only 25% of 
deans of top public health and medical schools. Sources: Women in Global Health.
3The Inter-Parliamentary Union reported that in 2019, out of a total of 1,412 
portfolios held by women, 109 were social affairs and 107 were family/children/ 
youth/elderly/disabled.
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Gender Backlash: Gender, Disgust and Right-wing 
Nationalism
The current political climate in certain countries is not propitious to careful, nuanced 
and evidence-led policy that is gender sensitive. Political backlash against pluralism 
and social diversity always has gender relations at its heart because far-right national-
ist populism likes to hark back to an imagined ideal past, when social relations and 
hierarchies were apparently immobile and unchallenged. Gender relations are often 
understood as the most primordial of hierarchical relations. Women are seen as the 
cornerstone of the family, as the primary agent of both physical reproduction (child-
birth and childrearing) and social reproduction (feeding, clothing and tending to the 
family members). In nearly all social–political imaginaries, the family is the microcosm 
of the ideal society, ergo women’s willingness to occupy this idealised role of mother 
and carer becomes central to any kind of nationalist project. If women are not willing 
to be ‘hostages to tradition’ and fall into line with conservative roles and behaviours, 
then they must be disciplined to do so. This explains why so many semi-authoritarian 
nationalist regimes move immediately to invoke moral panics about women’s bodies 
as part of a broader bio-political project, on the basis that uncontrolled women and 
fluid gender roles and relations constitute a form of degeneracy that will corrupt and 
contaminate the nation itself (Yuval-Davis, 1997).
Disciplining women’s bodies, and prohibiting nonbinary, non-heterosexual 
expressions of identity and sexuality is done both through legislation and social 
policy, and through developing a moralising climate that enables such moves. The 
current wave of far-right nationalists, from Trump in the USA, to Bolsonaro in 
Brazil, Putin in Russia and Orbán in Hungary, have all relied upon the mobilisa-
tion of visceral emotions – of which disgust is the most powerful and hard to 
resist rationally as it is the first emotion we learn – to stigmatise ‘outsider’ groups – 
refugees, homosexuals, bad women, drug users and criminals. The election of Jair 
Bolsonaro in Brazil in October 2018, which relied heavily on the transmission of 
fake news and memes via the closed family-and-friends networks of WhatsApp, 
relied heavily on outrageous statements by Bolsonaro and his campaign about the 
moral degeneracy of their opponents. They alleged, with no evidence, that their 
opponents, whilst in government, had distributed a ‘gay kit’ to primary schools to 
teach children to be homosexual, and that government nurseries had been using 
babies’ bottles with a teat shaped like a penis. Bolsonaro’s son declared that right-
wing women were ‘more hygienic’ than left-wing women who allegedly ‘bared 
their breasts in public and defecated in the street’.
This explains why such far-right movements often have similar policies of gen-
dered bio-politics, combining a pronatalist policy restricting reproductive choice 
and access to contraceptives, with criminalisation of abortion and of lesbian, gay, 
bisexual, transgender and questioning (LGBTQ) identities, and highly punitive 
policies on drug consumption and trade. These frequently turn into necropoli-
cies, as bodies that cannot be socially controlled are represented as bodies that 
may legitimately be eliminated. Thus, Duterte has summarily killed upwards of 
7,000 street-level drug users (Amnesty International, 2017). Bolsonaro has given 
the green light to police for similar shoot-to-kill policies, which will mainly target 
young black men.
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Conclusion
This chapter has discussed the immense challenges that women face in securing 
effective voice and representation in drug policy. The framing of women who use 
drugs and/or who are involved in drug supply as deviant and anomalous by policy 
actors has implications for the upholding and promotion of their human rights 
and for their autonomy, development prospects, security and health care. This is 
elaborated in subsequent contributions to this collection, including from the per-
spective of those with lived experience. There are two important messages from 
these chapters and from the collection as a whole. First, through creativity and 
innovation, women are finding a collective voice to challenge prohibitionist-based 
drug strategies, including in the most repressive social and political contexts. 
Second, that drug policy is a feminist issue. Drug policy is a driver of injustice, 
discrimination and stigmatisation of many women. Reform agendas need to be 
recognised, supported and adopted by feminist and women’s movements. In this 
respect, the following chapter takes a slightly different but important turn. It 
addresses the much neglected issue of pleasure in the use of drugs and it chal-
lenges the normative framing of women’s intoxication as a site of deviance and 
shaming. It introduces an auto-ethnographic approach adopted by other contri-
butions in this collection. As outlined by the author, ‘a scholarly activism by and 
inclusion of women who use drugs’ should be foundational to our analysis.
